"[W]e are playing nice in the sandbox" one generic drug maker wrote to a competitor. A recently filed lawsuit alleges that emails like that – and hundreds of other communications – are proof of a massive generic drug price-fixing scheme that has caused huge increases in costs to consumers.
Air Date: May 12, 2019
Sundays